about
Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewElectronegative LDL: a circulating modified LDL with a role in inflammationMolecular Model of Plasma PAF Acetylhydrolase-Lipoprotein Association: Insights from the Structure.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Approach to reduction of blood atherogenicityModified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Low-density lipoprotein electronegativity is a novel cardiometabolic risk factorKinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesisInfluence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional studyImpact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetesChemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoprotein.Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY StudyHighly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregationMolecular biology of atherosclerosis.Electronegative Low-Density Lipoprotein L5 Impairs Viability and NGF-Induced Neuronal Differentiation of PC12 Cells via LOX-1.Highly electronegative low-density lipoprotein L5 evokes microglial activation and creates a neuroinflammatory stress via Toll-like receptor 4 signaling.Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention.Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.The Induction of Cytokine Release in Monocytes by Electronegative Low-Density Lipoprotein (LDL) Is Related to Its Higher Ceramide Content than Native LDL.2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particlesAggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion.Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.Negatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patients.Reduced plasma zinc levels, lipid peroxidation, and inflammation biomarkers levels in hemodialysis patients: implications to cardiovascular mortality.High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level.Relation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresis.Aspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarction.Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
P2860
Q26991853-105E191A-D0C3-48D4-80D6-6DF3415F9ADEQ27015769-03CFC724-5B26-4D4B-BEE2-753B9B4A631AQ33664201-63211F1E-7D76-41D5-AB03-7B12CB5BCE78Q33879138-2F1920B2-50CD-4B77-B15C-962061F341BFQ33912060-D0AA9FFE-0BC0-4D33-8914-D6B0A73784BBQ34072528-3A6B2FFA-931D-428F-A8F1-7A5178F33931Q34156161-3B0A7FCF-3C36-48DD-B29F-5276EF92C5A6Q36213906-8293A905-81A9-41B0-944F-9685F4095B2CQ36707842-27FB25AE-BC79-4557-B57E-8B7E2D0210D3Q37112920-982023A9-C948-47A1-AD5D-F438B481222CQ37276420-AF373990-0460-4926-AF70-E4DC53E02EE4Q37299877-F5ADF9F6-5711-4ED1-95CE-D6B411CCBE88Q37334725-A51A132C-CAC1-4DA8-AB52-5F60EF6E462AQ38125279-81F5F3AF-0168-415B-93A0-A8326F210E01Q38628959-DC3BC556-E373-4B6E-AA84-8B8DC29AE672Q38819005-5FF4F551-BB82-412E-9A82-9F6E33837DC2Q39004398-FFB8A01C-7D28-4AF5-8F7A-497A5713046DQ41530349-F6DB2CB6-EE14-4616-82DE-99159D9E0E40Q41618607-510DDB47-BCFC-4412-82BE-B4656AE789FCQ41864548-2602E176-A121-4774-AE1E-12079D210E64Q42411907-F4374438-0F80-41F6-B6EC-FFCEC22E46DEQ42571163-5292DA99-5B7E-451F-A896-D1DFC208B63BQ44229858-5CF6F39D-B907-4FC9-917D-0229F76407A1Q51014048-84D98743-3D93-4BD9-BFBF-89E4A95688CAQ53724220-3F452D58-0E4B-4F6D-B023-530C1056372CQ53849228-7739441C-22A9-4BEE-8421-2E36CC04AC9EQ54442432-6D54A6E2-77C1-4D61-BEE8-1287AD436CFEQ58594575-EC2B9C57-4A17-432D-9F66-CEFDB9CBFA0F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Electronegative low-density lipoprotein.
@ast
Electronegative low-density lipoprotein.
@en
type
label
Electronegative low-density lipoprotein.
@ast
Electronegative low-density lipoprotein.
@en
prefLabel
Electronegative low-density lipoprotein.
@ast
Electronegative low-density lipoprotein.
@en
P2093
P1476
Electronegative low-density lipoprotein.
@en
P2093
Jordi Ordóñez-Llanos
José Luis Sánchez-Quesada
Sonia Benítez
P304
P356
10.1097/00041433-200406000-00014
P577
2004-06-01T00:00:00Z